Expression of miR-224, miR-145, and their putative target ADAM17 in hepatocellular carcinoma

Authors:

Abstract
MicroRNAs (miRNAs) have been demonstrated to involve in multiple biological processes, including apoptosis, proliferation, differentiation, and metastasis [1–3]. In addition, several groups have reported that abnormalities of specific miRNAs are implicated in cancer pathogenesis [4,5]. The roles of miR-224 and miR-145 in tumorigenesis have attracted the attention of many researchers. The protein A disintegrin and metalloproteinase 17 (ADAM17) is over-expressed in many types of cancers, including hepatocellular carcinoma (HCC). ADAM17 expression is regulated by multiple miRNAs, which have been identified in several types of cancers [6,7]. In silico analysis suggested that ADAM17 is a common target of both miR-224 and miR-145. In the present study, we investigated the expression and distribution of miR-224, miR-145, and ADAM17 in HCC samples and analyzed the relationship between both miRNAs and ADAM17.